The largest insider buys this week were for Jacobs Engineering Group Inc. (J, Financial), NiSource Inc. (NI, Financial), Amicus Therapeutics Inc. (FOLD, Financial) and PennyMac Financial Services Inc. (PFSI, Financial).
Jacobs Engineering Group director bought 10,000 shares
Director Christopher M.T. Thompson bought 10,000 shares of Jacobs Engineering (J, Financial) on May 26 for an average price of $140.22. The share price has increased by 2.27% since then.
Jacobs Engineering an American international engineering and construction firm that focuses on providing technical and construction services, including scientific and specialty consulting. Its clients include companies, organizations and government agencies. The company is a component of the S&P 500. The company has a market capitalization of $18.67 billion; as of June 4, it traded at $143.40.
On June 3, Jacobs Engineering announced it has been awarded two rail contracts by KiwiRail, the rail network owner and operator of New Zealand. The contracts are part of KiwiRail’s Auckland Metro Rail Program to modernize Auckland’s rail network, upgrading the existing rail network ahead of the opening of Auckland’s largest transport infrastructure project, the City Rail Link.
NiSource director bought 10,000 shares
Director Eric L. Butler bought 10,000 shares of NiSource (NI, Financial) stock on May 26 for an average price of $25.37. Since then, the stock has gained 0.47%.
NiSource is an American public utility company serving customers across seven states through its Columbia Gas and NIPSCO brands. The company serves approximately 3.5 million natural gas customers and 500,000 electric customers. The company has a market capitalization of $10 billion; as of June 4, it traded at $25.49.
On May 25, NiSource announced the board of directors has declared a quarterly common stock dividend of 22 cents per share. The dividend will be payable on Aug. 20 to stockholders of record at the close of business on July 30.
Amicus Therapeutics director bought 1,500 shares
Director Burke W. Whitman bought 1,500 shares of Amicus Therapeutics (FOLD, Financial) on June 1 for an average price of $9.24. The stock has gained 2.60% since then.
Amicus Therapeutics is an international biopharmaceutical company that focuses on developing and delivering medicines for people with rare metabolic diseases. The company is also a component of the Russell 2000. The company has a market capitalization of $2.52 billion; as of June 4, it traded at $9.48.
On May 10, Amicus Therapeutics reported financial results for the first quarter, which ended March 31. Total revenue for the quarter was $66.4 million, representing a 9.8% increase year over year. Total GAAP operating expenses for the quarter totaled $112.9 million, compared to $132 million for the same quarter a year ago. The net loss for the quarter was $65.7 million, or 25 cents per share, compared to a net loss of $88.9 million, or 35 cents per share.
PennyMac Financial Services director bought 46,990 shares
Director Nanji Farhad bought 46,990 sharesof PennyMac (PFSI, Financial) on June 1 for an average price of $62.67. Since then, the stock has declined 2.82%.
PennyMac Financial Services is an American residential mortgage company that focuses on producing and servicing mortgage loans in the United States and the management of mortgage market investments. The company is a component of the Russell 2000 and operates through two subsidiaries, PennyMac Loan Services LLC and PNMAC Capital Management LLC. The company has a market capitalization of $4.06 billion; as of June 4, it traded at $60.90.
On May 6, PennyMac Financial reported financial results for the first quarter of 2021. Net income for the quarter totaled $376.9 million, or $5.15 per share on a diluted basis. Revenue for the quarter totaled $944.7 million. The company also repurchased approximately 4.7 million shares of common stock at an approximate cost of $288.4 million.
For the complete list of stocks that were bought by their company executives, go to insider trades.
